Covid, still the great unknown?
Audio 19:30
Doses of the vaccine developed by the Johnson & Johnson laboratory.
In phase 3, the clinical trial of this candidate vaccine against Covid-19 must resume.
Cheryl Gerber / Johnson & Johnson via AP
By: Aurélien Devernoix
21 min
As Europe is in the process of reconfiguring itself, a lot of uncertainties persist around SARS-COV-2.
This new coronavirus causes Covid-19, this infectious disease that has already affected at least 45 million people across the planet, killing more than a million.
But if we now know how to detect the disease, treating it is still complicated and its origins and its evolutions keep a part of mystery.
Why so many difficulties for researchers around the world, what are the obstacles encountered by scientists?
These are the questions we are asking ourselves this evening in Decryption.
Publicity
Guest:
Morgane Bomse
l, research director at the CNRS and head of the mucosal immunity service at the Cochin Institute.
Newsletter
Receive all the international news directly in your mailbox
I subscribe
Follow all the international news by downloading the RFI application
google-play-badge_FR
Coronavirus